Patents Assigned to Boehringer Ingelheim Austria GmbH
  • Publication number: 20090263861
    Abstract: A host-vector system that uses the RNA-based copy number control mechanism of ColE1-type plasmids for regulating the expression of a marker gene allows for antibiotic-free selection of plasmids and is useful for production of plasmid DNA and recombinant proteins.
    Type: Application
    Filed: October 28, 2008
    Publication date: October 22, 2009
    Applicant: BOEHRINGER INGELHEIM AUSTRIA GMBH
    Inventors: Reingard GRABHERR, Irene PFAFFENZELLER
  • Publication number: 20090253182
    Abstract: A process for producing plasmid DNA E. coli cells comprises a pre-culture and fed-batch process. The culture media of the batch phase and the culture medium added during the feeding phase are chemically defined. The culture medium of the feeding phase contains a growth-limiting substrate and is added, for at least a fraction of the feeding phase, at a feeding rate that follows a pre-defined exponential function, thereby controlling the specific growth rate at a pre-defined value. The process results in high yield and homogeneity of plasmid DNA.
    Type: Application
    Filed: February 19, 2009
    Publication date: October 8, 2009
    Applicant: BOEHRINGER INGELHEIM AUSTRIA GMBH
    Inventors: Hans HUBER, Gerhard WEIGL, Wolfgang BUCHINGER
  • Publication number: 20090203069
    Abstract: Disclosed is a method for the production of a heterologous polypeptide of interest with a homogenous N-terminus, using a fusion polypeptide comprising the polypeptide of interest and N-terminally thereto a polypeptide exhibiting autoproteolytic function, said method comprising the steps of a) binding of the fusion polypeptide in a soluble, autoproteolytically inactive form by an affinity chromatography system, b) refolding of the fusion polypeptide, thereby activating the autoproteolytic function of the fusion polypeptide and causing cleavage of the heterologous polypeptide of interest, and c) subsequently eluting the heterologous polypeptide of interest, wherein said steps are conducted on one affinity chromatography system.
    Type: Application
    Filed: April 25, 2006
    Publication date: August 13, 2009
    Applicants: BOEHRINGER INGELHEIM AUSTRIA GMBH, SANDOZ AG
    Inventors: Alois Jungbauer, Rainer Hahn, Anne Tscheliessnig, Waltraud Kaar
  • Patent number: 7060460
    Abstract: In a method for reconstituting a recombinant protein from a denatured state to its active form, a feed solution containing the recombinant protein in its denatured and/or in biologically inactive intermediate forms is subjected to a chromatographic separation process, in which the protein is reconstituted under conditions that promote refolding of the protein and the intermediate forms are separated from the refolded protein. The denatured form and/or the inactive intermediate forms of the protein are separated from the refolded protein in a continuous or quasi-continuous manner and optionally recycled to the feed solution.
    Type: Grant
    Filed: October 2, 2002
    Date of Patent: June 13, 2006
    Assignee: Boehringer Ingelheim Austria GmbH
    Inventors: Roman Necina, Robert Schlegl, Alois Jungbauer, Christine Machold
  • Publication number: 20060063232
    Abstract: A host-vector system that uses the RNA-based copy number control mechanism of ColE1-type plasmids for regulating the expression of a marker gene allows for antibiotic-free selection of plasmids and is useful for production of plasmid DNA and recombinant proteins.
    Type: Application
    Filed: September 14, 2005
    Publication date: March 23, 2006
    Applicant: Boehringer Ingelheim Austria GmbH
    Inventors: Reingard Grabherr, Irene Pfaffenzeller
  • Publication number: 20050233421
    Abstract: A process for producing plasmid DNA E. coli cells comprises a pre-culture and fed-batch process. The culture media of the batch phase and the culture medium added during the feeding phase are chemically defined. The culture medium of the feeding phase contains a growth-limiting substrate and is added, for at least a fraction of the feeding phase, at a feeding rate that follows a pre-defined exponential function, thereby controlling the specific growth rate at a pre-defined value. The process results in high yield and homogeneity of plasmid DNA.
    Type: Application
    Filed: April 8, 2005
    Publication date: October 20, 2005
    Applicant: Boehringer Ingelheim AUSTRIA GmbH
    Inventors: Hans Huber, Gerhard Weigl, Wolfgang Buchinger
  • Publication number: 20050233365
    Abstract: A method for producing plasmid DNA on a manufacturing scale uses Escherichia coli K-12 strain JM108. The process results in high yield and homogeneity of plasmid DNA.
    Type: Application
    Filed: April 8, 2005
    Publication date: October 20, 2005
    Applicant: Boehringer Ingelheim AUSTRIA GmbH
    Inventors: Hans Huber, Claudia Pacher, Roman Necina, Franz Kollmann, Christoph Reinisch
  • Publication number: 20050026177
    Abstract: A scalable process and device for producing a biomolecule, in particular pharmaceutical grade plasmid DNA. The process includes the steps of alkaline lysis and a neutralization. For separating the lysate and the precipitate, the mixture is allowed to gently flow downward through a clarification reactor that is partially filled, in its lower part, with retention material like glass beads, whereby the precipitate is retained on top of and within the retention. In a preferred embodiment of the lysis step, cell suspension and alkaline lysis solution flow through a lysis reactor that is filled with particulate material like glass beads. The process can be run continuosly and fully automated.
    Type: Application
    Filed: March 23, 2004
    Publication date: February 3, 2005
    Applicant: Boehringer Ingelheim Austria GmbH
    Inventors: Jochen Urthaler, Roman Necina, Christine Ascher, Helga Woehrer